Home/Filings/4/0001438133-25-000165
4//SEC Filing

Sheridan John F 4

Accession 0001438133-25-000165

CIK 0001438133other

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 6:15 PM ET

Size

5.0 KB

Accession

0001438133-25-000165

Insider Transaction Report

Form 4
Period: 2025-08-11
Sheridan John F
EXECUTIVE VP AND COO
Transactions
  • Purchase

    Common Stock

    2025-08-11$10.23/sh+10,000$102,318106,327 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $10.19 to $10.33 per share. The reported price reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

TANDEM DIABETES CARE INC

CIK 0001438133

Entity typeother

Related Parties

1
  • filerCIK 0001365369

Filing Metadata

Form type
4
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 6:15 PM ET
Size
5.0 KB